About: Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 01 December 2006

Attributes	Values
rdf:type	Item
description	wetenschappelijk artikel (nl) article scientifique publié en 2006 (fr) наукова стаття, опублікована в грудні 2006 (uk) im Dezember 2006 veröffentlichter wissenschaftlicher Artikel (de) artículu científicu espublizáu n'avientu de 2006 (ast) scientific article published on 01 December 2006 (en)
publication date	wds:Q79402368-E72167D1-BF66-4FCB-B774-BFBE116519EB
publication date	2006-12-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q79402368-78C02C48-095C-45BF-9D37-97938CF15B24
language of work or name	English
author name string	wds:Q79402368-08C5A6B5-CD1B-4040-ACA6-48B932C1265C wds:Q79402368-80E2037B-BB25-4AE0-94E6-67C29F75AF51 wds:Q79402368-9A8FC64C-473A-4CE8-9F0B-329EF62DC864
author name string	Ronald van Vollenhoven Theodore Pincus Yusuf Yazici
rdfs:label	Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials (en) Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials (nl)
skos:prefLabel	Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials (en) Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials (nl)
name	Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials (en) Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials (nl)
title	wds:Q79402368-ADFEA81E-FD2B-453C-9FDE-A5E858268306
title	Why are only 50% of courses of anti-tumor necrosis factor agents continued for only 2 years in some settings? Need for longterm observations in standard care to complement clinical trials (en)
page(s)	wds:Q79402368-4B7FC738-8070-420A-A97A-DDF623AAE9D0
page(s)	2372-2375
instance of	wds:Q79402368-21797c18-2cc7-45f9-9498-d2436f7ca93c wds:Q79402368-577DAB17-EFB2-4E84-BA95-0D1D782704AE
instance of	editorial scholarly article
PubMed ID	wds:Q79402368-F158D94B-4692-4420-98C3-C941A3D42EFA
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/17143975
PubMed ID	17143975
published in	wds:Q79402368-7828382C-BDD4-48A3-9033-DD1D5282B8B8
published in	The Journal of Rheumatology
issue	wds:Q79402368-F018F86E-FAE5-42D1-BD03-B1B8F337683A
volume	wds:Q79402368-BA5275BD-ADDF-4E3A-8D1A-AA58BBD6BE25
issue	12
volume	33
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q79402368
is cites work of	Biologic agents-a panacea for inflammatory arthritis or not? A somatization comorbidity phenotype impacts response to therapy in rheumatoid arthritis: post-hoc results from the certolizumab pegol phase 4 PREDICT trial Is there a place for nonbiological drugs in the treatment of rheumatoid arthritis?
is cites work of	wds:Q41948703-60B4EAC1-965B-4D20-9F6F-CA38391F47FE wds:Q42368093-2D103201-DC11-46D4-A09B-C7CD8596011B wds:Q41809351-F91FD401-D711-4ABD-8C14-95DC3B0F3BA1

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software